European Patent Office

T 1699/17 (Modulation of EGFR with miRNA/UNIVERSITY OF WESTERN AUSTRALIA) of 04.08.2021

European Case Law Identifier
ECLI:EP:BA:2021:T169917.20210804
Date of decision
4 August 2021
Case number
T 1699/17
Online on
10 December 2021
Petition for review of
-
Application number
07800215.1
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
Method of modulation of expression of epidermal growth factor receptor (EGFR) involving miRNA
Applicant name
The University Of Western Australia
Opponent name
Müller Fottner Steinecke Rechtsanwalts- und
Patentanwaltspartnerschaft mbB
Board
3.3.01
Headnote
-
Relevant legal provisions
Rules of procedure of the Boards of Appeal Art 12Rules of procedure of the Boards of Appeal 2020 Art 013
Keywords
-
Catchword
-
Cited cases
-
Citing cases
-

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the opposition division with the order to maintain the patent with the following claims and a description to be adapted thereto:

claims 1 to 6 of the third auxiliary request, filed as corrected third auxiliary request during the oral proceedings of 4 August 2021.